Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3734898010 | Calamine- and dimeticone- and zinc oxide-containing product in cutaneous dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3734899019 | Product containing calamine and dimeticone and zinc oxide in cutaneous dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3734900012 | Calamine- and dimethicone- and zinc oxide-containing product in cutaneous dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4602591000052118 | läkemedel som innehåller dimetikon, kalamin och zinkoxid, kutan läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Calamine- and dimeticone- and zinc oxide-containing product in cutaneous dose form | Has manufactured dose form | Cutaneous dose form | true | Inferred relationship | Some | ||
| Calamine- and dimeticone- and zinc oxide-containing product in cutaneous dose form | Has active ingredient | Zinc oxide | true | Inferred relationship | Some | 3 | |
| Calamine- and dimeticone- and zinc oxide-containing product in cutaneous dose form | Is a | Product containing calamine in cutaneous dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Calamine- and dimeticone- and zinc oxide-containing product in cutaneous dose form | Has active ingredient | Calamine (substance) | true | Inferred relationship | Some | 1 | |
| Calamine- and dimeticone- and zinc oxide-containing product in cutaneous dose form | Has active ingredient | Dimeticone (substance) | true | Inferred relationship | Some | 2 | |
| Calamine- and dimeticone- and zinc oxide-containing product in cutaneous dose form | Is a | Product containing calamine and dimeticone and zinc oxide (medicinal product) | true | Inferred relationship | Some | ||
| Calamine- and dimeticone- and zinc oxide-containing product in cutaneous dose form | Is a | Calamine- and zinc oxide-containing product in cutaneous dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Is a | False | Calamine- and dimeticone- and zinc oxide-containing product in cutaneous dose form | Inferred relationship | Some | |
| Product containing only calamine and dimeticone and zinc oxide in cutaneous dose form (medicinal product form) | Is a | True | Calamine- and dimeticone- and zinc oxide-containing product in cutaneous dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR